Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Damora Therapeutics, Inc.
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 05, 2026
From
Damora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DMRA
Damora Therapeutics to Present New Preclinical Data Highlighting Potentially Best-in-Class Pan-Mutant Activity of DMR-001 in Mutant Calreticulin (mutCALR)-driven Myeloproliferative Neoplasms (MPN) at the American Society of Hematology (ASH) 2026 Annual
November 04, 2026
From
Damora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DMRA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Damora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DMRA
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2026
From
Damora Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DMRA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.